Nature's Sunshine Products Inc. Common Stock (NATR)

Stock · NASDAQ · Health Care

$14.21as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Resistance level

$20.49

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

NATR
Nature's Sunshine Products Inc. Common Stock
$14.22
▲ 2.16%
Market cap $371.74MP/E —
RCKT
Rocket Pharmaceuticals Inc. Common Stock
$3.86
▲ 6.49%
Market cap $372.35MP/E —
$2.53$5.45
ENTA
Enanta Pharmaceuticals Inc. Common Stock
$13.6
▼ 1.45%
Market cap $376.57MP/E —
$7.05$17.15
PBYI
Puma Biotechnology Inc Common Stock
$9.07
▼ 1.89%
Market cap $391.42MP/E 18.65
$4.3$9.51
DMAC
DiaMedica Therapeutics Inc. Common Stock
$6.39
▼ 5.33%
Market cap $351.32MP/E —
$5.14$10.42
UPB
Upstream Bio Inc. Common Stock
$6.68
▼ 1.62%
Market cap $349.38MP/E —
$5.85$33.68
EOLS
Evolus Inc. Common Stock
$8.89
▲ 0.06%
Market cap $398.42MP/E —
$3.86$9.12

Symbol	Market cap	P/E ratio	Price	1D	52-week range
NATR Nature's Sunshine Products Inc. Common Stock	$371.74M	—	$14.22	▲ 2.16%
RCKT Rocket Pharmaceuticals Inc. Common Stock	$372.35M	—	$3.86	▲ 6.49%	$2.53$5.45
ENTA Enanta Pharmaceuticals Inc. Common Stock	$376.57M	—	$13.6	▼ 1.45%	$7.05$17.15
PBYI Puma Biotechnology Inc Common Stock	$391.42M	18.65	$9.07	▼ 1.89%	$4.3$9.51
DMAC DiaMedica Therapeutics Inc. Common Stock	$351.32M	—	$6.39	▼ 5.33%	$5.14$10.42
UPB Upstream Bio Inc. Common Stock	$349.38M	—	$6.68	▼ 1.62%	$5.85$33.68
EOLS Evolus Inc. Common Stock	$398.42M	—	$8.89	▲ 0.06%	$3.86$9.12

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.